Solvay Pharma India Ltd.[Amalgamated] - Research Center
532447 DUPHARPH Group (N.A.) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 11 |
Dec' 10 |
Sep' 10 |
Jun' 10 |
Mar' 10 |
Sales |
79.99 |
76.03 |
84.19 |
73.94 |
62.75 |
Operating profit |
40.98 |
9.80 |
25.44 |
23.07 |
17.06 |
Interest |
- |
- |
- |
- |
- |
Gross profit |
22.88 |
10.85 |
26.52 |
23.86 |
17.82 |
EPS (Rs) |
22.20 |
13.68 |
34.13 |
30.53 |
22.36 |
Quarterly
results in details
|
Mar' 11 |
Dec' 10 |
Sep' 10 |
Jun' 10 |
Mar' 10 |
Other income |
1.52 |
1.06 |
1.07 |
0.80 |
0.75 |
Stock adjustment |
-8.97 |
4.35 |
0.73 |
-0.13 |
-4.22 |
Raw material |
19.87 |
10.62 |
15.14 |
13.22 |
15.48 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
9.25 |
9.95 |
9.30 |
7.07 |
7.40 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
18.86 |
41.31 |
33.57 |
30.71 |
27.02 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.73 |
0.82 |
0.80 |
0.80 |
0.79 |
Taxation |
5.30 |
3.13 |
8.48 |
7.65 |
5.74 |
Net profit / loss |
11.21 |
6.91 |
17.23 |
15.42 |
11.29 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
5.05 |
5.05 |
5.05 |
5.05 |
5.05 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
5.63 |
5.63 |
5.63 |
5.63 |
15.73 |
Agg.of non promotoholding (%) |
11.15 |
11.15 |
11.15 |
11.15 |
31.15 |
OPM (%) |
51.24 |
12.88 |
30.22 |
31.20 |
27.19 |
GPM (%) |
28.07 |
14.08 |
31.10 |
31.93 |
28.06 |
NPM (%) |
13.75 |
8.96 |
20.21 |
20.63 |
17.78 |